MBIOMustang Bio, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 18358
Ticker: MBIO
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2017-08-22
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MBIO

Detail

Enriched 2026-08-14 20:47

Market cap: $4,587,421.53
Shares outstanding (class): 6,732,121
Shares outstanding (weighted): 7,577,505
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 4
Location: WALTHAM, MA
Homepage: https://www.mustangbio.com
Description: Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Market cap and share counts drift.

Funds holding this security

2 funds · 2 positions · $18.8K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$18.7K	0.00%	25,704 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$116.48	0.00%	160 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMBIO
FIGI_COMPOSITEBBG00FXTN420
FIGI_SHARE_CLASSBBG00FXTN439
CIK0001680048
ISINUS62818Q3020
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, and Mustang Bio is a clinical-stage biopharmaceutical company.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.